232 related articles for article (PubMed ID: 24423350)
1. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study.
Morelli V; Reimondo G; Giordano R; Della Casa S; Policola C; Palmieri S; Salcuni AS; Dolci A; Mendola M; Arosio M; Ambrosi B; Scillitani A; Ghigo E; Beck-Peccoz P; Terzolo M; Chiodini I
J Clin Endocrinol Metab; 2014 Mar; 99(3):827-34. PubMed ID: 24423350
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
3. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
Eller-Vainicher C; Morelli V; Ulivieri FM; Palmieri S; Zhukouskaya VV; Cairoli E; Pino R; Naccarato A; Scillitani A; Beck-Peccoz P; Chiodini I
J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969
[TBL] [Abstract][Full Text] [Related]
4. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
Chiodini I; Morelli V; Salcuni AS; Eller-Vainicher C; Torlontano M; Coletti F; Iorio L; Cuttitta A; Ambrosio A; Vicentini L; Pellegrini F; Copetti M; Beck-Peccoz P; Arosio M; Ambrosi B; Trischitta V; Scillitani A
J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
[TBL] [Abstract][Full Text] [Related]
5. Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study.
Morelli V; Eller-Vainicher C; Salcuni AS; Coletti F; Iorio L; Muscogiuri G; Della Casa S; Arosio M; Ambrosi B; Beck-Peccoz P; Chiodini I
J Bone Miner Res; 2011 Aug; 26(8):1816-21. PubMed ID: 21472775
[TBL] [Abstract][Full Text] [Related]
6. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.
Morelli V; Palmieri S; Salcuni AS; Eller-Vainicher C; Cairoli E; Zhukouskaya V; Scillitani A; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2013 Feb; 168(2):235-41. PubMed ID: 23169694
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and metabolic risk factors in patients with subclinical Cushing.
Petramala L; Olmati F; Concistrè A; Russo R; Mezzadri M; Soldini M; De Vincentis G; Iannucci G; De Toma G; Letizia C
Endocrine; 2020 Oct; 70(1):150-163. PubMed ID: 32300953
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.
Perogamvros I; Vassiliadi DA; Karapanou O; Botoula E; Tzanela M; Tsagarakis S
Eur J Endocrinol; 2015 Dec; 173(6):719-25. PubMed ID: 26330465
[TBL] [Abstract][Full Text] [Related]
9. Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.
Salcuni AS; Morelli V; Eller Vainicher C; Palmieri S; Cairoli E; Spada A; Scillitani A; Chiodini I
Eur J Endocrinol; 2016 Mar; 174(3):261-9. PubMed ID: 26630908
[TBL] [Abstract][Full Text] [Related]
10. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.
Chiodini I; Viti R; Coletti F; Guglielmi G; Battista C; Ermetici F; Morelli V; Salcuni A; Carnevale V; Urbano F; Muscarella S; Ambrosi B; Arosio M; Beck-Peccoz P; Scillitani A
Clin Endocrinol (Oxf); 2009 Feb; 70(2):208-13. PubMed ID: 18547342
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study.
Chiodini I; Morelli V; Masserini B; Salcuni AS; Eller-Vainicher C; Viti R; Coletti F; Guglielmi G; Battista C; Carnevale V; Iorio L; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A
J Clin Endocrinol Metab; 2009 Sep; 94(9):3207-14. PubMed ID: 19549741
[TBL] [Abstract][Full Text] [Related]
12. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.
Morelli V; Eller-Vainicher C; Palmieri S; Cairoli E; Salcuni AS; Scillitani A; Carnevale V; Corbetta S; Arosio M; Della Casa S; Muscogiuri G; Spada A; Chiodini I
J Clin Endocrinol Metab; 2016 Jul; 101(7):2768-75. PubMed ID: 27144939
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas.
Yener S; Ertilav S; Secil M; Akinci B; Demir T; Kebapcilar L; Yesil S
Med Princ Pract; 2012; 21(5):429-34. PubMed ID: 22398948
[TBL] [Abstract][Full Text] [Related]
16. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
17. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
[TBL] [Abstract][Full Text] [Related]
18. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
[TBL] [Abstract][Full Text] [Related]
19. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
Olsen H; Olofsson L; Mjöman M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
[TBL] [Abstract][Full Text] [Related]
20. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.
Masserini B; Morelli V; Bergamaschi S; Ermetici F; Eller-Vainicher C; Barbieri AM; Maffini MA; Scillitani A; Ambrosi B; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2009 Jan; 160(1):87-92. PubMed ID: 18835977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
